Tc-sestamibi SPECT/CT-the jury is still out!
作者信息
Warren Hannah, Tran Maxine G B
机构信息
Division of Surgery and Interventional Sciences, University College London, London, UK.
Urology Department, Specialist Centre for Kidney Cancer, Royal Free Hospital, London, UK.
出版信息
Transl Androl Urol. 2024 Jun 30;13(6):1053-1055. doi: 10.21037/tau-23-623. Epub 2024 May 13.
Abstract
摘要
相似文献
1
Tc-sestamibi SPECT/CT-the jury is still out!
Transl Androl Urol. 2024 Jun 30;13(6):1053-1055. doi: 10.21037/tau-23-623. Epub 2024 May 13.
2
In Situ Metabolomics Expands the Spectrum of Renal Tumours Positive on Tc-sestamibi Single Photon Emission Computed Tomography/Computed Tomography Examination.
Eur Urol Open Sci. 2020 Nov 27;22:88-96. doi: 10.1016/j.euros.2020.11.001. eCollection 2020 Dec.
3
Cost-effectiveness Analysis of Tc-sestamibi SPECT/CT to Guide Management of Small Renal Masses.
Eur Urol Focus. 2021 Jul;7(4):827-834. doi: 10.1016/j.euf.2020.02.010. Epub 2020 Feb 27.
4
Tc-Sestamibi SPECT/CT and histopathological features of oncocytic renal neoplasia.
Scand J Urol. 2022 Oct-Dec;56(5-6):375-382. doi: 10.1080/21681805.2022.2119273. Epub 2022 Sep 5.
5
Prospective Evaluation of (99m)Tc-sestamibi SPECT/CT for the Diagnosis of Renal Oncocytomas and Hybrid Oncocytic/Chromophobe Tumors.
Eur Urol. 2016 Mar;69(3):413-6. doi: 10.1016/j.eururo.2015.08.056. Epub 2015 Sep 18.
6
Diagnostic Accuracy of Tc-Sestamibi SPECT/CT for Characterization of Solid Renal Masses.
J Nucl Med. 2023 Jan;64(1):90-95. doi: 10.2967/jnumed.122.264329. Epub 2022 Jun 30.
7
The Role of Tc-Sestamibi Single-photon Emission Computed Tomography/Computed Tomography in the Diagnostic Pathway for Renal Masses: A Systematic Review and Meta-analysis.
Eur Urol. 2024 Jan;85(1):63-71. doi: 10.1016/j.eururo.2023.07.013. Epub 2023 Sep 5.
8
Planar scintigraphy with 123I/99mTc-sestamibi, 99mTc-sestamibi SPECT/CT, 11C-methionine PET/CT, or selective venous sampling before reoperation of primary hyperparathyroidism?
J Nucl Med. 2013 May;54(5):739-47. doi: 10.2967/jnumed.112.109561. Epub 2013 Apr 3.
9
Use of quantitative SPECT/CT reconstruction in Tc-sestamibi imaging of patients with renal masses.
Ann Nucl Med. 2018 Feb;32(2):87-93. doi: 10.1007/s12149-017-1222-z. Epub 2017 Dec 6.
10
Technetium-99 m-sestamibi single-photon emission computerised tomography (CT)/CT in the prediction of malignant versus benign small renal masses.
BJU Int. 2022 Nov;130 Suppl 3:23-31. doi: 10.1111/bju.15737. Epub 2022 Apr 24.
本文引用的文献
1
The Role of Tc-Sestamibi Single-photon Emission Computed Tomography/Computed Tomography in the Diagnostic Pathway for Renal Masses: A Systematic Review and Meta-analysis.
Eur Urol. 2024 Jan;85(1):63-71. doi: 10.1016/j.eururo.2023.07.013. Epub 2023 Sep 5.
2
Clinical Performance of Technetium-99m-Sestamibi SPECT/CT Imaging in Differentiating Oncocytic Tumors From Renal Cell Carcinoma in Routine Clinical Practice.
J Urol. 2023 Sep;210(3):438-445. doi: 10.1097/JU.0000000000003557. Epub 2023 Jun 28.
3
Protocol for a MULTI-centre feasibility study to assess the use of Tc-sestaMIBI SPECT/CT in the diagnosis of kidney tumours (MULTI-MIBI study).
BMJ Open. 2023 Jan 24;13(1):e067496. doi: 10.1136/bmjopen-2022-067496.
4
Use of Tc-sestamibi SPECT/CT for indeterminate renal tumours: a pilot diagnostic accuracy study.
BJU Int. 2022 Dec;130(6):748-750. doi: 10.1111/bju.15879. Epub 2022 Sep 26.
5
Technetium-99 m-sestamibi single-photon emission computerised tomography (CT)/CT in the prediction of malignant versus benign small renal masses.
BJU Int. 2022 Nov;130 Suppl 3:23-31. doi: 10.1111/bju.15737. Epub 2022 Apr 24.
6
The value of Tc-sestamibi single-photon emission computed tomography-computed tomography in the evaluation and risk stratification of renal masses.
Can Urol Assoc J. 2021 Jun;15(6):197-201. doi: 10.5489/cuaj.6708.
7
The role of Tc-99m MIBI scintigraphy in clinical T1 renal mass assessment: Does it have a real benefit?
Urol Oncol. 2020 Dec;38(12):937.e11-937.e17. doi: 10.1016/j.urolonc.2020.07.018. Epub 2020 Aug 26.
8
Visual evaluation and differentiation of renal oncocytomas from renal cell carcinomas by means of Tc-sestamibi SPECT/CT.
EJNMMI Res. 2017 Dec;7(1):29. doi: 10.1186/s13550-017-0278-z. Epub 2017 Mar 29.
9
STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies.
BMJ. 2015 Oct 28;351:h5527. doi: 10.1136/bmj.h5527.
10
Prospective Evaluation of (99m)Tc-sestamibi SPECT/CT for the Diagnosis of Renal Oncocytomas and Hybrid Oncocytic/Chromophobe Tumors.
Eur Urol. 2016 Mar;69(3):413-6. doi: 10.1016/j.eururo.2015.08.056. Epub 2015 Sep 18.
Zotero 插件